Obesity in Adults: Causes, Health Consequences, and Treatment Methods
DOI:
https://doi.org/10.12775/QS.2024.17.53051Keywords
Obesity,, Epidemiology, Health Consequences, Physical Activity, Pharmacotherapy, Bariatric SurgeryAbstract
Introduction
Obesity is defined as an excessive accumulation of body fat that can negatively affect a person's physical as well as mental health. It results not only from excessive caloric intake relative to energy expenditure, but also from a myriad of genetic, metabolic, environmental and behavioral factors. Obesity poses the risk of a number of chronic diseases that impair quality of life and increase the risk of death. Understanding the causes of obesity, the consequences it brings, and learning about treatments can help improve health and public awareness.
Aim of the Study
This study aims to analyze the causes, health consequences, and available treatment methods for obesity in adults, providing a comprehensive overview of the current knowledge on the subject.
Materials and Methods
This review utilized data from recent literature published over the last 15 years, sourced primarily from PubMed. The focus was on identifying and synthesizing information related to the epidemiology, risk factors, health consequences, and treatment strategies for adult obesity. Keywords such as "obesity," "adult," "treatment," "epidemiology," and "health consequences" were used to search relevant studies.
Conclusions
Obesity in adults is a multifaceted issue requiring a comprehensive approach to treatment. Addressing this epidemic necessitates a combination of dietary changes, increased physical activity, behavioral therapies, pharmacological interventions, and surgical options when necessary. Ongoing support and monitoring are essential for achieving long-term success in weight management and improving overall health outcomes.
References
R. J. F. Loos and G. S. H. Yeo, “The genetics of obesity: from discovery to biology.,” Nat. Rev. Genet., vol. 23, no. 2, pp. 120–133, Feb. 2022, https://doi.org/10.1038/s41576-021-00414-z
L. Li et al., “Identification of Genetic and Environmental Factors Predicting Metabolically Healthy Obesity in Children: Data From the BCAMS Study.,” J. Clin. Endocrinol. Metab., vol. 101, no. 4, pp. 1816–1825, Apr. 2016, https://doi.org/10.1210/jc.2015-3760
G. A. Colditz et al., “Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention.,” Cancer Causes Control, vol. 11, no. 6, pp. 477–488, Jul. 2000, https://doi.org/10.1023/a:1008984432272
J. Henson, M. De Craemer, and T. Yates, “Sedentary behaviour and disease risk,” BMC Public Health, vol. 23, no. 1, pp. 23–25, 2023, https://doi.org/10.1186/s12889-023-16867-2.
T. Kondo et al., “Physical Frailty and Use of Guideline-Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction.,” J. Am. Heart Assoc., vol. 12, no. 12, p. e026844, Jun. 2023, https://doi.org/10.1161/JAHA.122.026844
F. B. Hu, “Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases.,” Obes. Rev. an Off. J. Int. Assoc. Study Obes., vol. 14, no. 8, pp. 606–619, Aug. 2013, https://doi.org/ 10.1111/obr.12040
P. Lavie, “Sleep-wake as a biological rhythm.,” Annu. Rev. Psychol., vol. 52, pp. 277–303, 2001, https://doi.org/10.1146/annurev.psych.52.1.277
J. M. Gorman and R. P. Sloan, “Heart rate variability in depressive and anxiety disorders.,” Am. Heart J., vol. 140, no. 4 Suppl, pp. 77–83, Oct. 2000, https://doi.org/10.1067/mhj.2000.109981
M. Geneshka, P. Coventry, J. Cruz, and S. Gilbody, “Relationship between Green and Blue Spaces with Mental and Physical Health: A Systematic Review of Longitudinal Observational Studies.,” Int. J. Environ. Res. Public Health, vol. 18, no. 17, Aug. 2021,
https://doi.org/10.3390/ijerph18179010.
E. S. van der Valk et al., “A comprehensive diagnostic approach to detect underlying causes of obesity in adults.,” Obes. Rev. an Off. J. Int. Assoc. Study Obes., vol. 20, no. 6, pp. 795–804, Jun. 2019, https://doi.org/10.1111/obr.12836
S. Singh, M. L. Ricardo-Silgado, S. J. Bielinski, and A. Acosta, “Pharmacogenomics of Medication-Induced Weight Gain and Antiobesity Medications.,” Obesity (Silver Spring)., vol. 29, no. 2, pp. 265–273, Feb. 2021, https://doi.org/10.1002/oby.23068.
C. J. Lavie, R. V Milani, and H. O. Ventura, “Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.,” J. Am. Coll. Cardiol., vol. 53, no. 21, pp. 1925–1932, May 2009, https://doi.org/10.1016/j.jacc.2008.12.068.
A. Akin Belli, S. Ozbas Gok, G. Akbaba, F. Etgu, and G. Dogan, “The relationship between rosacea and insulin resistance and metabolic syndrome.,” Eur. J. Dermatol., vol. 26, no. 3, pp. 260–264, Jun. 2016, https://doi.org/10.1684/ejd.2016.2748.
C. Eulenburg et al., “Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.,” Ann. Am. Thorac. Soc., vol. 20, no. 7, pp. 1048–1056, Jul. 2023, https://doi.org/10.1513/AnnalsATS.202208-676OC.
R. Shumnalieva, G. Kotov, and S. Monov, “Obesity-Related Knee Osteoarthritis-Current Concepts.,” Life (Basel, Switzerland), vol. 13, no. 8, Jul. 2023, https://doi.org/10.3390/life13081650.
A. Myers and J. C. Rosen, “Obesity stigmatization and coping: relation to mental health symptoms, body image, and self-esteem.,” Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes., vol. 23, no. 3, pp. 221–230, Mar. 1999,
https://doi.org/10.1038/sj.ijo.0800765.
E. Ko, H.-W. Seo, E. S. Jung, B. Kim, and G. Jung, “The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.,” Oncotarget, vol. 7, no. 1, pp. 684–699, Jan. 2016, https://doi.org/10.18632/oncotarget.6331.
C. L. van Vuuren et al., “Associations between overweight and mental health problems among adolescents, and the mediating role of victimization.,” BMC Public Health, vol. 19, no. 1, p. 612, May 2019, https://doi.org/10.1186/s12889-019-6832-z.
B. W. Sahle et al., “Association between depression, anxiety and weight change in young adults.,” BMC Psychiatry, vol. 19, no. 1, p. 398, Dec. 2019, https://doi.org/10.1186/s12888-019-2385-z.
Y. Kishida et al., “Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification.,” Bone, vol. 37, no. 5, pp. 607–621, Nov. 2005, https://doi.org/10.1016/j.bone.2005.05.009.
S. Westbury, O. Oyebode, T. van Rens, and T. M. Barber, “Obesity Stigma: Causes, Consequences, and Potential Solutions.,” Curr. Obes. Rep., vol. 12, no. 1, pp. 10–23, Mar. 2023,
https://doi.org/10.1007/s13679-023-00495-3.
J. Stephenson, C. M. Smith, B. Kearns, A. Haywood, and P. Bissell, “The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study.,” BMC Public Health, vol. 21, no. 1, p. 1990, Nov. 2021,
https://doi.org/10.1186/s12889-021-12009-8.
J. I. Hudson, E. Hiripi, H. G. J. Pope, and R. C. Kessler, “The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.,” Biol. Psychiatry, vol. 61, no. 3, pp. 348–358, Feb. 2007,
https://doi.org/10.1016/j.biopsych.2006.03.040.
C. M. Grilo, R. M. Masheb, M. Brody, C. H. Burke-Martindale, and B. S. Rothschild, “Binge eating and self-esteem predict body image dissatisfaction among obese men and women seeking bariatric surgery.,” Int. J. Eat. Disord., vol. 37, no. 4, pp. 347–351, May 2005, https://doi.org/10.1002/eat.20130.
G. Moschonis and G. L. Trakman, “Overweight and Obesity: The Interplay of Eating Habits and Physical Activity.,” Nutrients, vol. 15, no. 13. Switzerland, Jun. 2023. https://doi.org/10.3390/nu15132896.
T. M. Barber, P. Hanson, S. Kabisch, A. F. H. Pfeiffer, and M. O. Weickert, “The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations.,” Nutrients, vol. 13, no. 4, Apr. 2021,
https://doi.org/10.3390/nu13041187.
R. De Amicis, F. Menichetti, and A. Leone, “The Effect of the Mediterranean Diet on Metabolic Health.,” Nutrients, vol. 15, no. 15. Switzerland, Jul. 2023.
https://doi.org/10.3390/nu15153397.
L. Maïmoun, N. A. Georgopoulos, and C. Sultan, “Endocrine disorders in adolescent and young female athletes: impact on growth, menstrual cycles, and bone mass acquisition.,” J. Clin. Endocrinol. Metab., vol. 99, no. 11, pp. 4037–4050, Nov. 2014,
https://doi.org/10.1210/jc.2013-3030.
R. Dalle Grave, M. Sartirana, and S. Calugi, “Personalized cognitive-behavioural therapy for obesity (CBT-OB): theory, strategies and procedures.,” Biopsychosoc. Med., vol. 14, p. 5, 2020,
https://doi.org/10.1186/s13030-020-00177-9.
G. Castelnuovo et al., “Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives.,” Psychol. Res. Behav. Manag., vol. 10, pp. 165–173, 2017,
https://doi.org/10.2147/PRBM.S113278.
P. W. Breslin, “The psychological reactions of children to burn traumata: a review.,” IMJ. Ill. Med. J., vol. 148, no. 5, pp. 519–24 contd, Nov. 1975.
Z. Yida, M. U. Imam, M. Ismail, N. Ismail, A. Ideris, and M. A. Abdullah, “High fat diet-induced inflammation and oxidative stress are attenuated by N-acetylneuraminic acid in rats.,” J. Biomed. Sci., vol. 22, p. 96, Oct. 2015, https://doi.org/10.1186/s12929-015-0211-6.
J. Dushay et al., “Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes.,” Diabetes Care, vol. 35, no. 1, pp. 4–11, Jan. 2012, https://doi.org/10.2337/dc11-0931.
M. A. Nauck and D. A. D’Alessio, “Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.,” Cardiovasc. Diabetol., vol. 21, no. 1, p. 169, Sep. 2022,
https://doi.org/10.1186/s12933-022-01604-7.
L. van Bloemendaal et al., “GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.,” Diabetes, vol. 63, no. 12, pp. 4186–4196, Dec. 2014,
https://doi.org/10.2337/db14-0849.
Y. Liu et al., “The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials.,” Diabetol. Metab. Syndr., vol. 16, no. 1, p. 93, Apr. 2024,
https://doi.org/10.1186/s13098-024-01319-7.
D. Benaiges, A. Goday, J. Pedro-Botet, A. Más, J. J. Chillarón, and J. A. Flores-Le Roux, “Bariatric surgery: to whom and when?,” Minerva Endocrinol., vol. 40, no. 2, pp. 119–128, Jun. 2015.
A. B. Goldfine and M. E. Patti, “Diabetes improvement following Roux-en-Y gastric bypass: understanding dynamic changes in insulin secretion and action.,” Diabetes, vol. 63, no. 5, pp. 1454–1456, May 2014,
https://doi.org/10.2337/db13-1918.
F. Eghbali et al., “Predictors for weight loss after Roux-en-Y gastric bypass: the trend and associated factors for weight loss.,” BMC Surg., vol. 22, no. 1, p. 310, Aug. 2022,
https://doi.org/10.1186/s12893-022-01760-3.
A. Khalaj et al., “Two-year outcomes of sleeve gastrectomy versus gastric bypass: first report based on Tehran obesity treatment study (TOTS).,” BMC Surg., vol. 20, no. 1, p. 160, Jul. 2020, https://doi.org/10.1186/s12893-020-00819-3.
V. Consalvo, V. Salsano, and G. Sarno, “Three-Port Laparoscopic Adjustable Gastric Banding (LAGB): Surgical Technique and Three Years Follow-Up.,” Surg. Technol. Int., vol. 30, pp. 93–96, Jul. 2017.
G. Jabbour and A. Salman, “Bariatric Surgery in Adults with Obesity: the Impact on Performance, Metabolism, and Health Indices.,” Obes. Surg., vol. 31, no. 4, pp. 1767–1789, Apr. 2021, https://doi.org/10.1007/s11695-020-05182-z.
A. Ejaz, D. Wu, P. Kwan, and M. Meydani, “Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice.,” J. Nutr., vol. 139, no. 5, pp. 919–925, May 2009, https://doi.org/10.3945/jn.108.100966.
T. Ishii, T. Yamakita, T. Sato, S. Tanaka, and S. Fujii, “Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake.,” Diabetes Care, vol. 21, no. 8, pp. 1353–1355, Aug. 1998, https://doi.org/10.2337/diacare.21.8.1353.
M. Halberstam, N. Cohen, P. Shlimovich, L. Rossetti, and H. Shamoon, “Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.,” Diabetes, vol. 45, no. 5, pp. 659–666, May 1996, https://doi.org/10.2337/diab.45.5.659.
J. L. Ivy, “Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.,” Sports Med., vol. 24, no. 5, pp. 321–336, Nov. 1997,
https://doi.org/10.2165/00007256-199724050-00004.
M. A. van Baak, G. Hul, A. Astrup, and W. H. Saris, “Physical Activity, Weight Loss, and Weight Maintenance in the DiOGenes Multicenter Trial.,” Front. Nutr., vol. 8, p. 683369, 2021, https://doi.org/10.3389/fnut.2021.683369.
C. D. Madigan et al., “Effectiveness of weight management interventions for adults delivered in primary care: systematic review and meta-analysis of randomised controlled trials.,” BMJ, vol. 377, p. e069719, May 2022, https://doi.org/10.1136/bmj-2021-069719.
K. T. Jøranli, L. T. Vefring, M. Dalen, L. Garnweidner-Holme, and M. Molin, “Experiences of social support by participants with morbid obesity who participate in a rehabilitation program for health-behavior change: a qualitative study.,” BMC Nutr., vol. 9, no. 1, p. 149, Dec. 2023,
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Joanna Jakubiec, Julita Gmitrzuk, Zuzanna Malinka, Katarzyna Wiśniewska, Anna Jachymek, Martyna Opatowska, Tomasz Kucharski, Maciej Karasiński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 355
Number of citations: 0
